Clinical Trials Browser

Phase 2 × Withdrawn × zimberelimab × Clear all

NCT07283848 2025-12-26

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms